Wren

Asenapine

Asenapine is a prescription medicine well established for settling mania, the more severe high, and keeping future episodes away in adults with bipolar I.

Its tablets dissolve under the tongue, with food and drink waiting ten minutes afterwards. Sleepiness, dizziness and movement changes can make taking it difficult. In the UK, the Sycrest products listed on the electronic medicines compendium are marked discontinued, so continuing supply needs a specific plan.⁠

Asenapine is an antipsychotic, a group of medicines used for losing touch with reality, such as hearing voices or holding beliefs that are not true, and also for mood episodes. Sycrest and Saphris are brand names. Bipolar I includes a history of mania.⁠

What it helps with

Asenapine is well established for adult mania, alone or alongside lithium or valproate. The Canadian and international guideline places it among the first choices for that phase. The UK Sycrest product information licenses moderate to severe adult bipolar I mania; the US Saphris product also covers a severe high with low symptoms at the same time, often called a mixed state.⁠

Continuing asenapine is well established for prevention in bipolar I, particularly when it has already helped settle an episode. Its main role is treating highs and keeping episodes away; medicines for bipolar lows offer a separate set of choices when depression is the main difficulty.⁠

The tablet routine

The prescription sets the amount, usually with one dose in the morning and one in the evening. This form is sublingual, meaning under the tongue. Swallowing it allows very little medicine to be absorbed, so the routine matters.⁠

  1. A tablet is gently removed with dry hands by peeling back the blister when it is time to take it.

  2. The tablet is placed under the tongue and allowed to dissolve completely. It is kept whole, rather than crushed, chewed or swallowed.

  3. Food and drink wait ten minutes. When other medicines are due together, Sycrest is taken last.

Keeping a drink nearby for afterwards can make the waiting period easier to remember. If this routine is hard to manage, a pharmacist can demonstrate it and the prescriber can weigh whether another medicine would fit daily life better.⁠

For a missed Sycrest dose, the next dose is taken as usual; two doses are never taken to catch up. Two or more missed doses need advice from the doctor or pharmacist.⁠

Side effects and ways to manage them

Mouth effects, sleepiness and dizziness

The tablet can leave numbness or an altered feeling in the mouth, usually shortly after taking it. Letting the tablet dissolve in the intended place and keeping to the ten-minute wait preserves the taking routine. Continuing soreness or effects that make eating difficult deserve a pharmacist or prescriber review.⁠

Sleepiness can make mornings, work or travel harder. Driving, cycling and machinery need to wait until the person knows the medicine leaves them alert enough. Dizziness on standing can come from a drop in blood pressure; getting up slowly and sitting down when dizzy reduce the chance of falling.⁠

Movement, appetite and physical checks

A restless urge to move, shaking or stiffness can be medicine effects. Noting when they began, especially after starting or changing treatment, helps the prescriber review them alongside mood. New uncontrollable movements of the mouth, tongue or limbs need prompt medical advice.⁠

Weight and blood sugar can increase. Regular meals and planned snacks give hunger a predictable place in the day; activity fitted to mood and energy gives a manageable way to keep moving. Continuing weight changes or effects that interfere with daily life belong in a medicine discussion.⁠

Weight, blood pressure, blood sugar and fats in the blood need checks around starting and afterwards. The guideline recommends weight monthly for the first three months, then every three months, with blood pressure, sugar and fats at three months and yearly afterwards. These checks can find changes before the person feels unwell.⁠

Other medicines, alcohol and supply

Fluvoxamine, an antidepressant, can increase asenapine levels, and asenapine can increase the effects of paroxetine, another antidepressant. Medicines that lower blood pressure or cause sleepiness need checking too. A pharmacist needs the full list of medicines, supplements and herbal remedies when something is started or stopped. Sycrest's product information advises avoiding alcohol.⁠

The UK product listing marks both Sycrest strengths discontinued. Someone already taking it can ask the pharmacist and prescriber about remaining supply or an alternative before tablets run out. The listing describes those particular products; local availability needs checking for the actual prescription.⁠

Stopping, pregnancy and feeding

Stopping removes the medicine's protection against symptoms. A planned stop or switch is arranged with the prescriber, with follow-up for sleep and mood. NICE advises gradual reduction over at least four weeks when stopping an antipsychotic in bipolar. A supply change, sleepiness or difficulty with the tablet routine can all give a concrete starting point for a medicine discussion.⁠

Pregnancy information is limited. Planning treatment around pregnancy weighs the need to keep the parent well against risks to the baby. The UK Sycrest information advises against breastfeeding during treatment, making feeding and treatment a specific discussion.⁠

Problems needing urgent help

A high temperature with severe stiffness, sweating and reduced alertness needs emergency medical assessment. Sudden swelling of the tongue or throat, wheezing or collapse can be an allergic reaction, including after a first dose, and also needs emergency help. In England this means 999 or an emergency department. Taking more than prescribed needs urgent medical advice; marked sleepiness, breathing problems or collapse call for emergency help.⁠

Related: Medicines for bipolar · A medicine discussion · What helps when becoming high.

Sources

  1. 1The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence Guideline
  2. 2Sycrest 5mg sublingual tablets UK medicines guide
  3. 3SAPHRIS® (asenapine) sublingual tablets US product information
  4. 4Sycrest 5 mg sublingual tablets European patient leaflet
  5. 5Bipolar disorder: assessment and management NICE

Last updated 12 October 2026